Status of Clinical Hyperthermia

References

• Dahl O, Overgaard J. A century with hyperthermic oncology in Scandinavia. Acta Oncol 1995; 34: 1075–83.
   PubMed Web of Science ®Google Scholar
• Urano M, Douple E. Thermal effects on cells and tissues. In: Hyperthermia and oncology. Utrecht: VSP, 1988; 1: 1–214.
   Google Scholar
• Seegenschmiedt MH, Fessenden P, Vernon CC. Thermora-diotherapy and thermochemotherapy. Vol. 1 Biology physi-ology and physics. Philadelphia/Berlin: Springer Verlag, 1995: 1–483.
   Google Scholar
• Multhoff G, Hightower LE. Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaper-ones 1996; 1: 167–76.
   PubMed Web of Science ®Google Scholar
• Fuse T, Yoon K-W, Kato T, Yamada K. Heat-induced apoptosis in human glioblastoma cell line A172. Neuro-surgery 1998; 42: 843–9.
   Google Scholar
• Takasu T, Lyons JC, Park HJ, Song CW. Apoptosis and perturbation of cell cycle progression in an acidic environ-ment after hyperthermia. Cancer Res 1998; 58: 2504–8.
   PubMed Web of Science ®Google Scholar
• Toyota N, Strebel FR, Stephens LC, et al. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin combined with whole-body hyper-thermia in a rat mammary adenocarcinoma. Int .1- Cancer 1998; 76: 499–505.
   PubMed Web of Science ®Google Scholar
• Fajardo LF, Prionas SD, Kowalski J, Kwan HK. Hyper-thermia inhibits angiogenesis. Radiat Res 1988; 114: 297–306.
   PubMed Web of Science ®Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int .1- Radiat Oncol Biol Phys 1989; 16: 535–49.
   PubMed Web of Science ®Google Scholar
• Dahl O. Mechanisms of thermal enhancement of chemother-apeutic cytotoxicity. In: Urano M, Douple E, eds. Hyper-thermia and oncology. Utrecht: VSP. Vol 1994; 4: 28–49.
   Google Scholar
• Dahl O. Interaction of heat and drugs in vitro and in vivo. In: Seegenschmiedt MH, Fessenden P, Vernon CC, eds. Medical radiology-diagnostic imaging and radiation oncol-ogy. Berlin: Springer Verlag, ; Vol 1, 1995: 103–21.
   Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MCCH, et al. Hyperthermia as an adjuvant to radiation therapy of recur-rent or metastatic malignant melanoma. A multicenter ran-domized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3–20.
   PubMed Web of Science ®Google Scholar
• Sneed PK, Stauffer RP, McDermott MW, et al. Survival benefit of hyperthermia in a prospective randomized trial of branchytherapy boost + hyperthermia for glioblastoma mul-tiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287–95.
   PubMed Web of Science ®Google Scholar
• Leopold KA, Dewhirst M, Samulski T, et al. Relationships among tumor temperature, treatment time, and histopatho-logical outcome using preoperative hyperthermia with radia-tion in soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1992; 22: 989–98.
   PubMed Web of Science ®Google Scholar
• Field SB, Morris CC. The relationship between heating time and temperature: its relevance to clinical hyperthermia. Ra-diother Oncol 1983; 1: 179–86.
   PubMedGoogle Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787–800.
   PubMed Web of Science ®Google Scholar
• Leopold KA, Dewhirst MW, Samulski TV, et al. Cumulative minutes with T90 greater than temp,r,dex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol, Biol. Phys 1993; 25: 841–7.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Peer-Valstar JN, Rietveld PJM, de Graaf-Strukowska L, van Rhoon GC. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 1998; 40: 1205–12.
   PubMed Web of Science ®Google Scholar
• Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys 1998; 41: 1129–37.
   PubMed Web of Science ®Google Scholar
• Hand JW, Lagendijk JJW, Bach Andersen J, Bolomey JC. Quality assurance guidelines for ESHO protocols. Int J Hyperthermia 1989; 5: 421–8.
   PubMed Web of Science ®Google Scholar
• Lagendijk JJW, van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998; 14: 125–33.
   PubMed Web of Science ®Google Scholar
• Dewhirst MV, Phillips TL, Samulski TV, et al. RTOG quality guidelines for clinical trials using hyperthermia. Int .1-Radiat Oncol Biol Phys 1990; 18: 1249–59.
   PubMed Web of Science ®Google Scholar
• Carter DL, MacFall JR, Clegg ST, et al. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. Int .1- Radiat Oncol Biol Phys 1998; 40: 815–22.
   PubMed Web of Science ®Google Scholar
• Sennewald G, Turner PF, Schaefermeyer T, Latta M, Lau-ritzen R. Non-invasive treatment monitoring using a BSD-Sigma eye incorporated with a MRI system. In: Franconi C, Arcangeli G, Cavaliere R, eds. Hyperthermic oncology 1996; Vol 2: 412–3.
   Google Scholar
• Dewhirst MW, Prosnitz L, Thrall D, et al. Hyperthermic treatment of malignant diseases: current status and a view toward the future. Semin Oncol 1997; 24: 616–25.
   PubMed Web of Science ®Google Scholar
• Kapp DS, Petersen IA, Cox RS, et al. Two or six hyperther-mia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. Int .1-Radiat Oncol Biol Phys 1990; 19: 1481–95.
   PubMed Web of Science ®Google Scholar
• Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radia-tion therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int .1- Radiat Oncol Biol Phys 1994; 28: 163–9.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Nielsen OS. The importance of thermotoler-ance for the clinical treatment with hyperthermia. Radiother Oncol 1983; 1: 167–78.
   PubMedGoogle Scholar
• Emami B, Myerson RJ, Cardenes H, et al. Combined hyper-thermia and irradiation in the treatment of superficial tu-mors: results of a prospective randomized trial of hyperthermia fractionation (l/wk vs 2/wk). Int .1- Radiat Oncol Biol Phys 1992; 24: 145–52.
   PubMed Web of Science ®Google Scholar
• Engin K, Tupchong L, Moylan DJ, et al. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours. Int .1- Hyperther-mia 1993; 9: 327–30.
   PubMed Web of Science ®Google Scholar
• Sullivan DM, Ben-Yosef R, Kapp DS. Stanford 3D hyper-thermia treatment planning system. Technical review and clinical summary. Int .1- Hyperthermia 1993; 9: 627–43.
   PubMed Web of Science ®Google Scholar
• Hornsleth SN. Radiofrequency regional hyperthermia. Heat-ing technology, quality assurance, treatment planning. The-sis. Bergen: Bergen University, 1996.
   Google Scholar
• Wust P, Seebass M, Nabodny J, Deuflhard P, Monich G, Felix R. Simulation studies promote technological develop-ment of radiofrequency phased array hyperthermia. Int .1-Hyperthermia 1996; 12: 477–94.
   PubMed Web of Science ®Google Scholar
• Turner PF, Schaefermeyer T, Saxton T. Future trends in heating technology of deep-seated tumors. Recent Results Cancer Res 1988; 107: 249–62.
   PubMedGoogle Scholar
• Dahl EO. Quality assurance system for the BSD 2000 hyper-thermia system. Thesis. Bergen: University of Bergen, 1998: 1–115.
   Google Scholar
• Hornsleth SN, Frydendal L, Mella O, Dahl O, Raskmark P. Quality assurance for radio frequency regional hyperther-mia. Int .1- Hyperthermia 1997; 13: 169–85.
   PubMed Web of Science ®Google Scholar
• Myerson RJ, Perez CA, Emami B, et al. Tumor control in long-term survivors following superficial hyperthermia. Int .1-Radiat Oncol Biol Phys 1990; 18: 1123–9.
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Langholz B, Gibbs FA, et al. Regional hyper-thermia for advanced tumors: a clinical study of 353 pa-tients. Int .1- Radiat Oncol Biol Phys 1989; 16: 601–7.
   PubMed Web of Science ®Google Scholar
• Sapozink MD, Joszef G, Astrahan MA, Gibbs Jr. FA, Petrovich Z, Stewart JR. Adjuvant pelvic hyperthermia in advanced cervical carcinoma. I. Feasibility, thermometry and device comparison. Int J Hyperthermia 1990; 6: 985–96.
   PubMed Web of Science ®Google Scholar
• Feldmann HJ, Molls M, Heinemann H-G, Romanowski R, Stuschke M, Sack H. Thermoradiotherapy in locally advanced deep seated tumours-thermal parameters and treat-ment results. Radiother Oncol 1993; 26: 38–44.
   Google Scholar
• Overgaard J, Bach Andersen J. Hyperthermia. In: Peckham M, Pinedo H, Veronesi U, eds. Oxford textbook of oncol-ogy. Oxford: Oxford University Press, 1995; Vol 1: 1823–35.
   Google Scholar
• Overgaard J, Gonzalez DG, Hulshof MCCM, et al. Ran-domized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540–3.
   PubMed Web of Science ®Google Scholar
• Lindholm C-E, Kjellen E, Nilsson P, Hertzman S. Mi-crowave-induced hyperthermia and radiotherapy in human superficial tumours: clinical results with a comparative study of combined treatment versus radiotherapy alone. Int J Hyperthermia 1987; 3: 393–411.
   Google Scholar
• Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial local-ized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996; 35: 731–44.
   PubMed Web of Science ®Google Scholar
• van der Zee J, van der Holt B, Rietveld P, et al. Reirradia-tion combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer 1999; 79: 483–90.
   PubMed Web of Science ®Google Scholar
• Arcangeli G, Barni E, Cividalli A, et al. Effectiveness of microwave hyperthermia combined with ionizing radiation: clinical results on neck node metastases. Int J Radiat Oncol Biol Phys 1980; 6: 143–8.
   PubMed Web of Science ®Google Scholar
• Valdagni R, Kapp DS, Valdagni C. N3 (TNM-UICC) metastatic neck nodes managed by combined radiation ther-apy and hyperthermia: clinical results and analysis of treat-ment parameters. Int J Hyperthermia 1986; 2: 189–200.
   Google Scholar
• Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clini-cal trial. Int J Radiat Oncol Biol Phys 1988; 15: 13–24.
   Google Scholar
• Amichetti M, Romano M, Busana L, et al. Hyperfraction-ated radiation in combination with local hyperthermia in the treatment of advanced squamous cell carcinoma of the head and neck: a phase I-II study. Radiother Oncol 1997; 45: 155–8.
   PubMed Web of Science ®Google Scholar
• Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990; 6: 479–86.
   PubMed Web of Science ®Google Scholar
• Overgaard J, van der Zee J, Vernon C, Gonzalez Gonzalez D, Arcangeli G. Thermoradiotherapy of malignant tumors. European randomized multicenter trials evaluating the effect of adjuvant hyperthermia in radiotherapy. In: Kogelnik HD, ed. 5th International Meeting on Progress in Radio-Oncol-ogy ICRO/0GRO 5. Salzburg (Austria): Monduzzi Editore SpA, 1995: 507–13.
   Google Scholar
• Kapp DS. Editorial comment: a phase III study on hyper-thermia in head and neck canine tumours: not hot enough. Int J Hyperthermia 1996; 12: 437–41.
   PubMed Web of Science ®Google Scholar
• Wust P, Stahl H, Dieckmann K, et al. Local hyperthermia of N2/N3 cervical lymph node metastases: correlation of tech-nical/thermal parameters and response. Int J Radiat Oncol Biol Phys 1996; 34: 635–46.
   PubMed Web of Science ®Google Scholar
• Stahl H, Wust P, Graf R, et al. Phase-I/II- Studie zur lokalen Hyperthermie zervikaler N2/N3- Lymphknoten-metastasen. Strahlenther Onkol 1997; 173: 219–29.
   PubMedGoogle Scholar
• Perez CA, Pajak T, Emami B, Hornback NB, Tupchong L, Rubin P. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial mea-surable tumors. Am J Clin Oncol 1991; 14: 133–41.
   PubMed Web of Science ®Google Scholar
• Perez CA, Gillespie B, Pajak T, Hornback NB, Emami B, Rubin P. Quality assurance problems in clinical hyperther-mia and their impact on local therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int .1- Radiat Oncol Biol Phys 1989; 16: 551–8.
   PubMed Web of Science ®Google Scholar
• van der Zee J, GonzalesGonzales D, Vernon CC, et al. Therapeutic gain by hyperthermia added to radiotherapy. In: Kogelnik HD, Sedlmayer E, eds. 'Progress in radio-oncology VI.' Bologna: Monduzzi Editore, 1998: 137–145.
   Google Scholar
• Komaki R, Brickner TJ, Hanlon AL, Owen JB, Hanks GE. Long-term results of treatment of cervical carcinoma in the United States in, 1978 and 1983: patterns of care study (PCS). Int .1- Radiat Oncol Biol Phys ; 31 1973; 1995: 973–82.
   Google Scholar
• Takeshi K, Katsuyuki K, Yoshiaki T, et al. Definitive radio-therapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: retrospective analy-sis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys 1998; 41: 319–27.
   PubMed Web of Science ®Google Scholar
• Kapp KS, Stuecklschweiger GF, Kapp DS, et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1998; 42: 531–40.
   PubMed Web of Science ®Google Scholar
• Perez CA, Grigsby PW, Chao KSC, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998; 41: 307–17.
   PubMed Web of Science ®Google Scholar
• Leborgne F, Leborgne JH, Doldán R, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997; 37: 343–50.
   Google Scholar
• Shueng P, Hsu W, Jen Y, Wu C, Liu H. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 1998; 40: 889–96.
   Google Scholar
• Zanetta G, Lissoni A, Pellegrino A, et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 1998; 9: 977–80.
   PubMed Web of Science ®Google Scholar
• Melia O, Dahl O, Horn A, Morild I, Odland G. Radiother-apy and resection for apparently inoperable rectal adenocar-cinoma. Dis Colon Rectum 1984; 27: 663–8.
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Hohenberger P, et al. Preoperative hyper-thermia combined with radiochemotherapy in locally ad-vanced rectal cancer. Ann Surg 1998; 227: 380–9.
   PubMed Web of Science ®Google Scholar
• Wust P, Rau B, Gellermann J, et al. Radiochemotherapy and hyperthermia in the treatment of rectal cancer. Cancer Res 1998; 146: 175–91.
   Google Scholar
• Korenaga D, Matsushima T, Adachi Y, et al. Preoperative hyperthermia combined with chemotherapy and radiother-apy for patients with rectal carcinoma may prevent early local pelvic recurrence. Int J Colorect Dis 1992; 7: 206–9.
   PubMed Web of Science ®Google Scholar
• Ohno S, Tomoda M, Tomisaki S, et al. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis Colon Rectum 1997; 40: 401–6.
   PubMed Web of Science ®Google Scholar
• Trotter JM, Edis AJ, Blackwell JB, et al. Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancer. Australas Radiol 1996; 40: 298–305.
   PubMedGoogle Scholar
• Berdov BA, Menteshashvili GZ. Thermoradiotherapy of pa-tients with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990; 6: 881–90.
   PubMed Web of Science ®Google Scholar
• You Q-S, Wang R-Z, Suen G-Q, et al. Combination preop-erative radiation and endocavitary hyperthermia for rectal cancer: long-term results of 44 patients. Int J Hyperthermia 1993; 9: 19–24.
   PubMed Web of Science ®Google Scholar
• Heald RJ, Rya11 RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; Jun 28, 1: 1479–82.
   Google Scholar
• Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335–46.
   PubMed Web of Science ®Google Scholar
• Strotsky A, Fradkin S, Zhavrid E, Karpovich U. Combined therapy of bladder cancer with the use of hyperthermia. Strahlenther Onkol 1991; 167: 346.
   Google Scholar
• Seegenschmiedt MH, Klautke G, Seidel R, Stauffer P. Clini-cal practice of interstitial thermoradiotherapy. In: Seegen-schmiedt MH, Fessenden P, Vernon CC, eds. Thermoradiotherapy and thermochemotherapy. Vol 2. Clini-cal applications. Berlin: Springer, 1995: 207–62.
   Google Scholar
• Emami B, Scott C, Perez CA, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial ra-diotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1996; 34: 1097–104.
   PubMed Web of Science ®Google Scholar
• Ueo H, Sugimachi K. Preoperative hyperthermochemoradio-therapy for patients with esophageal carcinoma or rectal carcinoma. Semin Surg Oncol 1990; 6: 8–13.
   PubMedGoogle Scholar
• Sugimachi K, Kitamura K, Baba K, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus-a prospective random-ized trial. Int J Hyperthermia 1992; 8: 289–95.
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective ran-domized trial. Int J Hyperthermia 1994; 10: 485–93.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Kuwano H, Watanabe M, et al. Prospective randomized study of hyperthermia combined with chemora-diotherapy for esophageal carcinoma. J Surg Oncol 1995; 60: 55–8.
   PubMed Web of Science ®Google Scholar
• Issels RD, Mittermfiller J, Gerl A, et al. Improvement of local control by regional hyperthermia combined with sys-temic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: Updated report on 65 patients. J Cancer Res Clin Oncol 1991; 117: S141–7.
   PubMed Web of Science ®Google Scholar
• Issels RD, Bosse D, Starck M, et al. Weichteiltumoren: Indikation und ergebnisse der Hyperthermie. Chirurg 1993; 64: 461–7.
   PubMed Web of Science ®Google Scholar
• Issels RD, Bosse D, Abdel-Rahman S, et al. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma. A pilot study. Cancer Chemother Pharmacol 1993; 31: S233–7.
   Google Scholar
• Multhoff G, Botzler C, Wiesnet M, et al. A stress-inducible 72-kDa heat-shock protein (H5P72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 1995; 61: 272–9.
   PubMed Web of Science ®Google Scholar
• Kim JH, Hahn EW, Antich PP. Radiofrequency hyperther-mia for clinical cancer therapy. Natl Cancer Inst Monogr 1982; 61: 339–42.
   Google Scholar
• Petersen IA, Kapp DS. Local hyperthermia and radiation therapy in the retreatment of superficially located recur-rences in Hodgkin's disease. Int J Radiat Oncol Biol Phys 1990; 18: 603–11.
   PubMed Web of Science ®Google Scholar
• Donato V, Zurlo A, Nappa M, et al. Multicentre experience with combined hyperthermia and radiation therapy in the treatment of superficially located non-Hodgkin's lymphomas. J Exp Clin Res 1997; 16: 87–90.
   PubMed Web of Science ®Google Scholar
• Colombo R, Lev A, Freschi M, Gallus G, Rigatti P. Neoad-juvant combined microwave-induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superfi-cial bladder cancer. J Urol 1996; 155: 1227–32.
   Google Scholar
• Arcangeli G, Cividalli A, Mauro F, Nervi C, Pavin G. Enhanced effectiveness of adriamycin and bleomycin com-bined with local hyperthermia in neck node metastases from head and neck cancers. Tumori 1979; 65: 481–6.
   Google Scholar
• Pilepich MV, Jones KG, Emami BN, Perez CA, Fields JN, Myerson RJ. Interaction of bleomycin and hyperthermia-results of a clinical pilot study. Int J Radiat Oncol Biol Phys 1989; 16: 211–3.
   PubMed Web of Science ®Google Scholar
• Cumberlin R, De Moss E, Lassus M, Friedman M. Isola-tion perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 1985; 3: 1022–31.
   PubMed Web of Science ®Google Scholar
• Lejeune FJ, Deloof T, Ewalenko P, et al. Objective regres-sion of unexcised melanoma in-transit metastases after hy-perthermic isolation perfusion of the limbs with melphalan. Recent Results Cancer Res 1983; 86: 268–2676.
   PubMedGoogle Scholar
• Lienard D, Lejeune FJ, Ewalenko P. In transit metastases of malignant melanoma treated by high dose rTNFalpha in combination with interferon-7 and melphalan in isolation perfusion. World J Surg 1992; 16: 234–40.
   Google Scholar
• Ghussen F, Kruger I, Groth W, Stützer H. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 1988; 61: 654–9.
   Google Scholar
• Ghussen F, Kruger I, Smalley RV, Groth W. Hyperthermic perfusion with chemotherapy for melanoma of the extremi-ties. World J Surg 1989; 13: 598–602.
   PubMed Web of Science ®Google Scholar
• Hafstrom L, Rudenstam C-M, Blomquist E, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J Clin Oncol 1991; 9: 2091–4.
   Google Scholar
• Koops HS, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized high-risk limb melanoma: re-sults of a multicenter randomized phase III trial. J Clin Oncol 1998; 16: 2906–12.
   PubMed Web of Science ®Google Scholar
• Klicks RJ, Vrouenraets BC, Nieweg OE, Kroon BBR. Vas-cular complications of isolated limb perfusion. Eur J Surg Oncol 1998; 24: 288–2891.
   PubMed Web of Science ®Google Scholar
• Cavaliere R, Di Filippo F, Cavaliere F, et al. Clinical practice of hyperthermic extremity perfusion in combination with radiotherapy and chemotherapy. In: Seegen-schmiedt MH, Fessenden P, Vernon CC, eds. Thermoradio-therapy and thermochemotherapy. Berlin: Springer. Vol 1995; 2: 323–45.
   Google Scholar
• Pettigrew R, Lugate C. Whole-body hyperthermia. A sys-temic treatment for disseminated cancer. Recent Results Cancer Res 1977; 59: 153–70.
   Google Scholar
• van der Zee J, van Rhoon GC, Wike-Hooley J, Faithfull N, Reinhold H. Whole-body hyperthermia in cancer ther-apy: a report of a phase I-II study. European Journal of Clinical Oncology 1983; 19: 1189–200.
   Web of Science ®Google Scholar
• Bull JM, Lees D, Schuette W, et al. Whole body hyperther-mia: a phase4 trial of a potential adjuvant to chemother-apy. Ann Intern Med 1979; 90: 317–23.
   PubMed Web of Science ®Google Scholar
• Robins HI. Role of whole-body hyperthermia in the treat-ment of neoplastic disease: its current status and future prospects. Cancer Res 1984; 44: 4878S–4883.
   Google Scholar
• Engelhardt R, Muller U, Weth-Simon R, Neumann HA, Löhr GW. Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin. Int J Hyperthermia 1990; 6: 511–5.
   Google Scholar
• Wiedemann G, Robins H, Gutsche S, et al. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8°C whole body hyperthermia in patients with refractory sar-coma. Eur J Cancer 1996; 32A: 888–92.
   Google Scholar
• Robins H, Rushing D, Kutz M, et al. Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in can-cer patients. J Clin Oncol ; 15. 1997: 158–64.
   Google Scholar
• Engelhardt R. Summary of recent clinical experience in whole-body hyperthermia combined with chemotherapy. Recent Results Cancer Res 1988; 107: 200–4.
   PubMedGoogle Scholar
• Lindholm C-E, Kjellen E, Nilsson P, Weber L, Hill S. Prognostic factors for tumour response and skin damage to combined radiotherapy and hyperthermia in superficial re-current breast carcinomas. Int J Hyperthermia 1995; 11: 337–55.
   Google Scholar